BAGSVAERD, DENMARK--(Marketwire - May 05, 2011) -
At its Capital Markets Day today, Novo Nordisk outlines the aspirations for
how
to sustain competitiveness in the global pharmaceutical industry.
Company Announcement no 27 2011:
http://hugin.info/2013/R/1512418/448279.pdf
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Novo Nordisk A/S via Thomson Reuters ONE
[HUG#1512418]
Media:
Mike Rulis
Tel: (+45) 4442 3573
Email Contact
In North America
Ken Inchausti
Tel: (+1) 609 786 8316
Email Contact
Investors:
Klaus Bulow Davidsen
Tel: (+45) 4442 3176
Email Contact
Jannick Lindegaard
Tel: (+45) 4442 4765
Email Contact
Frank Daniel Mersebach
Tel: (+45) 4442 0604
Email Contact
In North America
Hans Rommer
Tel: (+1) 609 216 4834
Email Contact